Modeling human congenital disorders with neural crest developmental defects using patient-derived induced pluripotent stem cells

• Main Authors: Hironobu Okuno, Hideyuki Okano
• Format: Article
• Language: English
• Published: Elsevier 2021-12-01
• Series: Regenerative Therapy
• Subjects: iPS cells derived neural crest cells; Neurocristopathy; Disease modeling
• Online Access: http://www.sciencedirect.com/science/article/pii/S2352320421000602

The neural crest is said to be the fourth germ layer in addition to the ectoderm, mesoderm and endoderm because of its ability to differentiate into a variety of cells that contribute to the various tissues of the vertebrate body. Neural crest cells (NCCs) can be divided into three functional groups: cranial NCCs, cardiac NCCs and trunk NCCs. Defects related to NCCs can contribute to a broad spectrum of syndromes known as neurocristopathies. Studies on the neural crest have been carried out using animal models such as Xenopus, chicks, and mice. However, the precise control of human NCC development has not been elucidated in detail due to species differences. Using induced pluripotent stem cell (iPSC) technology, we developed an in vitro disease model of neurocristopathy by inducing the differentiation of patient-derived iPSCs into NCCs and/or neural crest derivatives. It is now possible to address complicated questions regarding the pathogenetic mechanisms of neurocristopathies by characterizing cellular biological features and transcriptomes and by transplanting patient-derived NCCs in vivo. Here, we provide some examples that elucidate the pathophysiology of neurocristopathies using disease modeling via iPSCs.